Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2024 call → NOThe question asks whether management describes that successive engagements of the same kind are coming in at progressively larger size — i.e., that the deals/contracts/projects/customers it is landing now are individually bigger, broader, or longer than before for the same offering. Let me scan the transcript for any such description. Kevin Blair discusses growth in middle-market, CIB, specialty lines. He mentions "built our largest CIB pipeline to date" — but that's a pipeline, not actual landed deals, and it's about volume/pipeline size, not unit size of individual deals. He mentions "expanded existing relationships with approximately 75% of our treasury sales to existing clients" — that's about expansion of relationships, not necessarily larger individual deals. He mentions "we are excited to introduce a differentiated new solution called Accelerate Pay" — new product, not escalation of size. He mentions "we finalized our new GreenSky program" — new program. He mentions "generated over 50 new relationships from our business owner wealth strategy" — new relationships, not larger size. He mentions "grew wealth AUM by 12% year-over-year" — growth, not unit size. He mentions "added a new commodities hedging capability" — new capability. Nothing about deals, orders, contracts, projects, customers, sites, or programs coming in at progressively larger size. Jamie Gregory discusses loan growth, deposit growth, etc. Nothing about escalating unit size. Robert Derrick discusses credit quality. There's no mention of average deal size increasing, customers starting at larger scope, follow-on commitments at multiples, etc. The only thing close is "built our largest CIB pipeline to date" — but that's a pipeline, not landed deals, and it's about total pipeline, not individual deal size. Also, it's a pipeline, not actual signed deals. There's no comparison against the company's own recent past regarding unit size of engagements. So the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.